Verve Therapeutics, Inc. earnings per share and revenue

VERV earnings per share for the last quarter are -0.59 USD whereas the estimation was -0.68 USD which accounts for 13.69% surprise. Company revenue for the same period amounts to 6.87 M USD despite the estimated figure of 2.75 M USD. Estimated earnings per share for the next quarter are -0.68 USD, and revenue is expected to reach 3.57 M USD. Also watch annual changes over time to get a bigger picture of VERV earnings per share and revenue dynamics.